Clinical Trial Update: Clinical Study of U01（ssCART-19） in Patients With B-Cell Lymphoma [Phase 1]

View source ↗

Summary

A Phase 1 study of U01 (ssCART-19) for B-cell lymphoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Non-hodgkin Lymphoma

Drugs mentioned

• U01 (ssCART-19)

Snippet

Sponsor: Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd | Conditions: B Cell Lymphoma | Phase 1 | Status: RECRUITING